Acitretin - 98%, high purity , Retinoid receptor agonist, CAS No.55079-83-9, Retinoid receptor agonist

Item Number
A102064
Grouped product items
SKUSizeAvailabilityPrice Qty
A102064-25mg
25mg
4
$53.90
A102064-100mg
100mg
9
$132.90
A102064-250mg
250mg
4
$299.90
A102064-1g
1g
5
$1,077.90
A102064-5g
5g
2
$4,847.90
A102064-25g
25g
2
$21,815.90

Synthetic, highly lipophilic retinoid

Basic Description

SynonymsAcitretin | ACITRETIN [HSDB] | (2E,4E,6E,8E)-3,7-dimethyl-9-[2,3,6-trimethyl-4-(methyloxy)phenyl]nona-2,4,6,8-tetraenoic acid | AKOS015889991 | Q341500 | Ro-10-1670 | SMR000499573 | 9-cis Acitretin | Soriatane | Neotigason | Acitretin- Bio-X | Z2312273468
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsSynthetic retinoid that is a metabolite of etretinate. Preferentially binds to cellular retinoic acid binding proteins (CRABPs).Synthetic, highly lipophilic retinoid. Etretinate metabolite with a shorter half-life. Increases ADAM10 gene expression. Induce
Storage TempProtected from light,Store at -20°C,Argon charged
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionRetinoid receptor agonist
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

It is a potent activator of the α-secretase ADAM10 gene expression and apoptosis inducer via the CD95 signalling pathway. It is also a systemic retinoid drug used in the treatment of severe psoriasis.

AI Insight

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

Pubchem Sid488195292
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488195292
IUPAC Name (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid
INCHI InChI=1S/C21H26O3/c1-14(8-7-9-15(2)12-21(22)23)10-11-19-16(3)13-20(24-6)18(5)17(19)4/h7-13H,1-6H3,(H,22,23)/b9-7+,11-10+,14-8+,15-12+
InChi Key IHUNBGSDBOWDMA-AQFIFDHZSA-N
Canonical SMILES CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC
Isomeric SMILES CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C)C)C)OC
WGK Germany 3
PubChem CID 5284513
UN Number 3077
Molecular Weight 326.43

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

16 results found

Lot NumberCertificate TypeDateItem
L1213051Certificate of AnalysisSep 03, 2024 A102064
D2304390Certificate of AnalysisMar 01, 2023 A102064
D2304391Certificate of AnalysisMar 01, 2023 A102064
D2304394Certificate of AnalysisMar 01, 2023 A102064
D2304395Certificate of AnalysisMar 01, 2023 A102064
D2304396Certificate of AnalysisMar 01, 2023 A102064
D2304398Certificate of AnalysisMar 01, 2023 A102064
D2304408Certificate of AnalysisMar 01, 2023 A102064
D2304409Certificate of AnalysisMar 01, 2023 A102064
D2304410Certificate of AnalysisMar 01, 2023 A102064
B2322233Certificate of AnalysisFeb 28, 2023 A102064
B1915042Certificate of AnalysisDec 09, 2022 A102064
B1915040Certificate of AnalysisDec 09, 2022 A102064
A2303320Certificate of AnalysisSep 24, 2021 A102064
I2116029Certificate of AnalysisSep 24, 2021 A102064
I2116030Certificate of AnalysisSep 24, 2021 A102064

Show more⌵

Safety and Hazards(GHS)

Pictogram(s) GHS08,   GHS09,   GHS07
Signal Danger
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H400:Very toxic to aquatic life

H410:Very toxic to aquatic life with long lasting effects

H360:May damage fertility or the unborn child

Precautionary Statements

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P362+P364:Take off contaminated clothing and wash it before reuse.

P391:Collect spillage.

P203:Obtain, read and follow all safety instructions before use.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P318:if exposed or concerned, get medical advice.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

WGK Germany 3
Merck Index 112

Related Documents

Reviews

Customer Reviews

Citations of This Product

1. Yongjie Bao, Wenni Rong, An Zhu, Yuan Chen, Huiyue Chen, Yirui Hong, Jingyang Le, Qiyao Wang, C. Benjamin Naman, Zhipeng Xu, Lin Liu, Wei Cui, Xiang Wu.  (2023)  Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction.  Pharmaceutics,  15  (9): (2311).  [PMID:37765280] [10.3390/pharmaceutics15092311]

References

1. Yongjie Bao, Wenni Rong, An Zhu, Yuan Chen, Huiyue Chen, Yirui Hong, Jingyang Le, Qiyao Wang, C. Benjamin Naman, Zhipeng Xu, Lin Liu, Wei Cui, Xiang Wu.  (2023)  Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction.  Pharmaceutics,  15  (9): (2311).  [PMID:37765280] [10.3390/pharmaceutics15092311]

Solution Calculators